LT-002-158 Tablets: Clinical Trials

2 trials of LT-002-158 Tablets, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 2
Phase 22Recruiting 2

Follow LT-002-158 Tablets: new trials by email Literature Review of LT-002-158 Tablets trials Research Report on LT-002-158 Tablets

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa
LT-002-158 Tablets - Hidradenitis Suppurativa (HS)
Phase 1 / Phase 2RecruitingLeadingtac Pharmaceutical (Shaoxing) Co., Ltd.122025-07-082026-08-27
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis
LT-002-158 tablets - Atopic Dermatitis (AD)
Phase 1 / Phase 2RecruitingLeadingtac Pharmaceutical (Shaoxing) Co., Ltd.242025-06-042026-08-27

Conditions studied

Dermatitis, Atopic (1)  ·  Hidradenitis Suppurativa (1)

Sponsors

Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. (2)

Countries

China (2)